In studies of DCM [39], autoimmune prostatitis [40], cerebral ischemia [41], and other diseases, modulation of the PI3K/AKT pathway has been shown to inhibit NLRP3 activation and regulate downstream inflammatory factor expression. The gene discussed is AKT1; the disease is brain ischemia.